We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PHIA:EURONEXT AMSTERDAMKoninklijke Philips N.V. Analysis

Data as of 2026-09-04 - not real-time

€22.35

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Koninklijke Philips N.V. is bearish at €22.35, with short-term averages lagging the long-term ones. It has lost 1.4% over the past 30 days. RSI sits at 41.8, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at €22.72 up to resistance at €24.22.
The shares look undervalued, trading on 19.6 times earnings below a sector average of 31.0. The average analyst target implies 20.8% above today's level. The 3.72% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 20.6%, a beta of 0.30 and a maximum drawdown of 20.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top Market Events

Koninklijke Philips N.V. surprised positively with better?than?expected quarterly earnings, keepingKoninklijke Philips N.V. is repositioning itself as a focused health technology group after restructYahoo Finance8dKoninklijke Philips N.V. R PHIA.F Q4 FY2025 earnings call transcriptPhilips delivered 7% YoY Q4 sales...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 23.85
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 19.6 versus sector average of 31.0
  • Trading below the 200-day average of 23.85

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 19.6 versus sector average of 31.0
  • Analyst targets imply +20.8% versus the current price
  • Dividend yield of 3.72%

Key Metrics & Analysis

Financial Health

Revenue Growth0.50%
Profit Margin6.31%
P/E Ratio19.6
ROE10.15%
ROA4.07%
Debt/Equity65.05
P/B Ratio1.9
Op. Cash Flow€2.3B
Free Cash Flow€1.5B
Industry P/E31.0

Technical Analysis

TrendBearish
RSI41.8
Support€22.72
Resistance€24.22
MA 20€23.33
MA 50€23.47
MA 200€23.85
MACDBearish
VolumeDecreasing
Fear & Greed Index95.86

Valuation

Fair Value€14.36
Target Price€27.00
Upside/Downside20.78%
GradeUndervalued
TypeValue
Dividend Yield3.72%

Risk Assessment

Beta0.30
Volatility20.62%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.